Home › Funds › HAHN CAPITAL MANAGEMENT LLC › LH

HAHN CAPITAL MANAGEMENT LLC position in LH

LABCORP HOLDINGS INC · Health Care

HAHN CAPITAL MANAGEMENT LLC reported holding 24,090 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 4.35% of its reported portfolio and ranking #8 among its reported holdings. HAHN CAPITAL MANAGEMENT LLC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)24.09K sh
Reported value held$7.42M
Portfolio Weight4.35%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HAHN CAPITAL MANAGEMENT LLC's LH position evolved

HAHN CAPITAL MANAGEMENT LLC first disclosed a stake in LH in Q3 2023 at 48,903 shares (US$9.8M). The position peaked in Q4 2023 at 47,019 shares, worth US$10.7M. Across 13 filings, HAHN CAPITAL MANAGEMENT LLC increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 24,090 shares valued at US$7.4M — a reduction of -1,363 shares quarter over quarter.. Notable position changes include a 37% trim in Q1 2024 (shares fell 7% over the following quarter), a 34% trim in Q3 2024 (shares rose 3% over the following quarter), a 48% increase in Q4 2024 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 48.90K $9.83M New
Q4 2023 47.02K $10.69M Reduce
Q1 2024 29.65K $6.48M Reduce
Q2 2024 39.54K $8.05M Add
Q3 2024 26.23K $5.86M Reduce
Q4 2024 38.72K $8.88M Add
Q1 2025 35.12K $8.17M Reduce
Q2 2025 34.60K $9.08M Reduce
Q3 2025 33.19K $9.53M Reduce
Q4 2025 31.28K $7.85M Reduce
Q1 2026 26.17K $6.98M Reduce
Q2 2026 25.45K $7.13M Reduce
Q3 2026 24.09K $7.42M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has HAHN CAPITAL MANAGEMENT LLC held LH?

HAHN CAPITAL MANAGEMENT LLC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is HAHN CAPITAL MANAGEMENT LLC's current position in LH?

As of Q3 2026, HAHN CAPITAL MANAGEMENT LLC holds 24.09K shares of LH (LABCORP HOLDINGS INC), valued at $7.42M, representing 4.35% of its reported portfolio and ranking #8.

Has HAHN CAPITAL MANAGEMENT LLC been buying or selling LH?

In the latest 13F filing (Q3 2026), HAHN CAPITAL MANAGEMENT LLC reduced its position in LH. The position peaked in Q4 2023 at 47.02K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.